Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Insulin Resistance Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Insulin Resistance Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
$2,000 | March 2022 Insulin resistance pipeline market research report provides comprehensive information on the therapeutics under development for Insulin Resistance, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Insulin Resistance and features dormant and...
-
Product Insights
Phenylketonuria (PKU) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Phenylketonuria (PKU) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
$2,000 | March 2022 Phenylketonuria (PKU) pipeline market research report provides comprehensive information on the therapeutics under development for phenylketonuria (PKU), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and...
-
Product Insights
Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
$2,000 | April 2022 Diabetic Nephropathy pipeline market research report provides comprehensive information on the therapeutics under development for Diabetic Nephropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and...
-
Product Insights
Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
$2,500 | April 2022 Dyslipidemia pipeline market research report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects.
-
Product Insights
Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021 Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021
$2,500 | December 2021 This report provides top-line data relating to the clinical trials on diabetic foot infection (DFI). This report includes an overview of trials count and their average enrollment in top countries conducted globally. Moreover, the report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. It also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials). The diabetic Foot Infection (DFI)...
-
Product Insights
Hyperinsulinemia - Global Clinical Trials Review, H2, 2021 Hyperinsulinemia - Global Clinical Trials Review, H2, 2021
$2,500 | December 2021 This report provides top-line data relating to the clinical trials on hyperinsulinemia. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. Moreover, the report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials). Hyperinsulinemia clinical trial report consists of 106 trials....
-
Product Insights
Gestational Diabetes Global Clinical Trials Review, H1, 2016 Gestational Diabetes Global Clinical Trials Review, H1, 2016
$2,500 | March 2016 GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, H1, 2016" provides an overview of Gestational Diabetes clinical trials scenario. This report provides top line data relating to the clinical trials on Gestational Diabetes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Fabry Disease Global Clinical Trials Review, H1, 2016 Fabry Disease Global Clinical Trials Review, H1, 2016
$2,500 | March 2016 GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, H1, 2016" provides an overview of Fabry Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Fabry Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016 Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016
$2,500 | April 2016 GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Gaucher Disease Global Clinical Trials Review, H1, 2016 Gaucher Disease Global Clinical Trials Review, H1, 2016
$2,500 | April 2016 GlobalData's clinical trial report, “Gaucher Disease Global Clinical Trials Review, H1, 2016" provides an overview of Gaucher Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.